NuVasive (NUVA) to Pay $60M in NeuroVision Brand Name Litigation

October 28, 2010 9:48 AM EDT

NuVasive, Inc. (Nasdaq: NUVA) announced that they have received an unfavorable result in litigation tied to the NeuroVision® brand name.

As a result, the company will pay $600 million in damages, though the amount is subject to change.

Nuvasive plans to appeal the decision.

Any payment of damages will be delayed with the posting of a supersedeas bond, in an amount yet to be determined, while the appeals process runs its course which could take up to 2 years.

---

Are you missing key trading opportunities? Upgrade to StreetInsider Premium and get a step ahead of the market - FREE TRIAL!

Create E-mail AlertRelated Categories

Corporate News

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?